JAMES SLATTON: Open Payments
NPI 1699234351 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 28 payments from 15 companies in 2025. Trend: 2023 $324 · 2024 $386 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| PFIZER INC. | 3 | $66 |
| Lilly USA, LLC | 3 | $59 |
| Dexcom, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: LEQVIO, VRAYLAR, Dexcom G6 Transmitter, Ozempic, MOUNJARO, Symbravo, GVOKE HYPOPEN, JARDIANCE.
Industry payments across TN — which companies pay providers there.
